
newsbiomarkercanakinumab
Molecular Biomarkers Predicting Canakinumab Tapering Success in Systemic Juvenile Idiopathic Arthritis
By MedXY|Oct 2, 2026
This study identifies serum and gene expression signatures predicting successful canakinumab tapering in systemic juvenile idiopathic arthritis, offering precision medicine strategies to reduce flares.